- Home
- RARE vs EBC Comparison
RARE vs EBC Comparison
Compare RARE & EBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- EBC
- Stock Information
- Founded
- RARE 2010
- EBC 1818
- Country
- RARE United States
- EBC United States
- Employees
- RARE N/A
- EBC N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- EBC Accident &Health Insurance
- Sector
- RARE Health Care
- EBC Finance
- Exchange
- RARE Nasdaq
- EBC Nasdaq
- Market Cap
- RARE 3.5B
- EBC 3.5B
- IPO Year
- RARE 2014
- EBC 2020
- Fundamental
- Price
- RARE $36.68
- EBC $15.24
- Analyst Decision
- RARE Strong Buy
- EBC Buy
- Analyst Count
- RARE 15
- EBC 2
- Target Price
- RARE $90.53
- EBC $19.25
- AVG Volume (30 Days)
- RARE 1.1M
- EBC 1.7M
- Earning Date
- RARE 07-31-2025
- EBC 07-24-2025
- Dividend Yield
- RARE N/A
- EBC 3.40%
- EPS Growth
- RARE N/A
- EBC N/A
- EPS
- RARE N/A
- EBC N/A
- Revenue
- RARE $590,689,000.00
- EBC $457,519,000.00
- Revenue This Year
- RARE $18.94
- EBC $25.36
- Revenue Next Year
- RARE $28.93
- EBC $27.80
- P/E Ratio
- RARE N/A
- EBC N/A
- Revenue Growth
- RARE 33.46
- EBC N/A
- 52 Week Low
- RARE $29.59
- EBC $13.51
- 52 Week High
- RARE $60.37
- EBC $19.40
- Technical
- Relative Strength Index (RSI)
- RARE 51.86
- EBC 56.11
- Support Level
- RARE $36.03
- EBC $14.72
- Resistance Level
- RARE $37.74
- EBC $15.02
- Average True Range (ATR)
- RARE 1.46
- EBC 0.33
- MACD
- RARE -0.01
- EBC 0.05
- Stochastic Oscillator
- RARE 26.56
- EBC 77.40
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About EBC Eastern Bankshares Inc.
Eastern Bankshares Inc is a commercial bank that caters its products and services to retail, commercial, and small business customers. Its diversified products and services include lending, deposit, wealth management, and insurance products. The company has one operating segment; Banking business which offers a range of banking lending, savings, and small business offerings, and its wealth management and trust operations.